Skip to main content
OpenTrials

Clinical trial condition

Psoriasis

Explore clinical trials studying Psoriasis. Study availability and eligibility vary by location and protocol.

933 public trials 73 recruiting studies
Refine in advanced search Browse all conditions

Psoriasis trial results

Completed

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

NCT03210259

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 49 locations
View Trial Details
Completed

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

NCT03478787

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Advanced Research Associates - Glendale /ID# 204335 Glendale, Arizona, United States
  • Alliance Dermatology and MOHs /ID# 204336 Phoenix, Arizona, United States
  • Bakersfield Derma & Skin Cance /ID# 202115 Bakersfield, California, United States
  • Center for Dermatology Clin Res /ID# 202116 Fremont, California, United States
View all 61 locations
View Trial Details
Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

NCT03343639

Conditions
Pathological Conditions, Signs and Symptoms, Pruritus, Psoriasis, +5 more
Locations
  • Study Site 221 Bryant, Arkansas, United States
  • Study Site 220 Beverly Hills, California, United States
  • Study Site 204 Fremont, California, United States
  • Study Site 356 San Diego, California, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

NCT03922607

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Derm Ctr /ID# 222593 Birmingham, Alabama, United States
  • Alliance Dermatology and MOHs /ID# 222622 Phoenix, Arizona, United States
  • Anaheim Clinical Trials LLC /ID# 213645 Anaheim, California, United States
  • Dermatology Res. Assoc., CA /ID# 224980 Los Angeles, California, United States
View Trial Details
Completed

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

NCT03875508

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Advanced Research Associates /ID# 210634 Glendale, Arizona, United States
  • Cognitive Clinical Trials /ID# 210770 Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research /ID# 211386 Hot Springs, Arkansas, United States
  • Bakersfield Derma & Skin Cance /ID# 210773 Bakersfield, California, United States
View all 26 locations
View Trial Details
Completed

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

NCT03535194

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • David Stoll, M.D. Beverly Hills, California, United States
  • California Dermatology and Clinical Research Institute Encinitas, California, United States
View all 178 locations
View Trial Details
Completed

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis

NCT02195349

Conditions
Hypersensitivity, Hypersensitivity, Delayed, Immune System Diseases, +4 more
Locations
  • GSK Investigational Site Bonn, North Rhine-Westphalia, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site London, United Kingdom
View Trial Details

Related conditions